Literature DB >> 23910894

Presenting life with cystic fibrosis: a Q-methodological approach to developing balanced, experience-based prenatal screening information.

Katherine F Wright1, Louise D Bryant2, Stephen Morley2, Jenny Hewison2, Alistair J A Duff3, Daniel Peckham3.   

Abstract

BACKGROUND: Cystic fibrosis (CF) is one of the most common life-threatening genetically inherited conditions and prenatal screening for CF is available in many countries. Genetic counsellors and other health professionals are expected to provide information about the condition in a way that facilitates personal decision making. Knowing what information to deliver about complex genetic conditions to support informed screening decisions can be challenging for health professionals.
OBJECTIVE: To solicit views from those with personal experience with CF on which aspects of the condition they consider most important to include in prenatal screening materials.
METHODS: Q-methodology; an approach to systematically explore variations in viewpoint that combines factor analytic techniques with qualitative approaches to pattern interpretation. SETTING AND PARTICIPANTS: Twelve adults with CF and 18 parents of affected children were recruited from a regional centre in the UK.
RESULTS: Five distinct viewpoints on the items most and least important to include in screening information were identified: Factor 1 the normality of life with CF and increasing life expectancy; Factor 2 the hardships and reduced lifespan. Factor 3 medical interventions and the importance of societal support. Factor 4 longer-term consequences of CF. Factor 5 the ability to adjust to the condition. DISCUSSION: The identification of five different views on what represented the most and least important information to include about CF highlights the challenge of portraying a complex genetic condition in a balanced and accurate manner. Novel ways in which Q-methodology findings can be used to meet this challenge are presented.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  Q methodology; cystic fibrosis; prenatal screening information

Mesh:

Year:  2013        PMID: 23910894      PMCID: PMC5060888          DOI: 10.1111/hex.12113

Source DB:  PubMed          Journal:  Health Expect        ISSN: 1369-6513            Impact factor:   3.377


  30 in total

1.  Descriptive information about Down syndrome: a content analysis of serum screening leaflets.

Authors:  L D Bryant; J Murray; J M Green; J Hewison; I Sehmi; A Ellis
Journal:  Prenat Diagn       Date:  2001-12       Impact factor: 3.050

2.  Choices and rights: eugenics, genetics and disability equality.

Authors:  Tom Shakespeare
Journal:  Disabil Soc       Date:  1998-11

3.  Disability rights critique of prenatal genetic testing: reflections and recommendations.

Authors:  Erik Parens; Adrienne Asch
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2003

4.  Considering 'balance' in information.

Authors:  Vikki Entwistle
Journal:  Health Expect       Date:  2007-12       Impact factor: 3.377

Review 5.  ACOG Committee Opinion No. 486: Update on carrier screening for cystic fibrosis.

Authors: 
Journal:  Obstet Gynecol       Date:  2011-04       Impact factor: 7.661

6.  Understanding genetic disease in a socio-historical context: a case study of cystic fibrosis.

Authors:  Anne Kerr
Journal:  Sociol Health Illn       Date:  2005-11

7.  'Balance' is in the eye of the beholder: providing information to support informed choices in antenatal screening via Antenatal Screening Web Resource.

Authors:  Shenaz Ahmed; Louise Bryant; Jenny Hewison
Journal:  Health Expect       Date:  2007-12       Impact factor: 3.377

Review 8.  Adaptation to living with a genetic condition or risk: a mini-review.

Authors:  B B Biesecker; L Erby
Journal:  Clin Genet       Date:  2008-09-24       Impact factor: 4.438

9.  An assessment of written patient information provided at the genetic clinic and relating to genetic testing in seven European countries.

Authors:  Celine Lewis; Pritti Mehta; Alastair Kent; Heather Skirton; Domenico Coviello
Journal:  Eur J Hum Genet       Date:  2007-06-13       Impact factor: 4.246

Review 10.  Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review.

Authors:  J M Green; J Hewison; H L Bekker; L D Bryant; H S Cuckle
Journal:  Health Technol Assess       Date:  2004-08       Impact factor: 4.014

View more
  3 in total

1.  Preconception expanded carrier screening: Impact of information presented by text or video on genetic knowledge and attitudes.

Authors:  Thirsa Conijn; Stephanie C M Nijmeijer; Phillis Lakeman; Lidewij Henneman; Frits A Wijburg; Lotte Haverman
Journal:  J Genet Couns       Date:  2020-09-17       Impact factor: 2.537

2.  "I didn't take it too seriously because I'd just never heard of it": Experiential knowledge and genetic screening for thalassaemia in the UK.

Authors:  Felicity K Boardman; Rachel Hale
Journal:  J Genet Couns       Date:  2018-12-24       Impact factor: 2.537

3.  What results to disclose, when, and who decides? Healthcare professionals' views on prenatal chromosomal microarray analysis.

Authors:  Shiri Shkedi-Rafid; Angela Fenwick; Sandi Dheensa; Diana Wellesley; Anneke M Lucassen
Journal:  Prenat Diagn       Date:  2016-02-17       Impact factor: 3.050

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.